ArticleInternational journal of urology : official journal of the Japanese Urological Association2025
Preoperative Pyuria as a Predictor of False-Positive Rates in the Photodynamic Diagnosis of Nonmuscle-Invasive Bladder Cancer Using Oral 5-Aminolevulinic Acid.
Article in International journal of urology : official journal of the Japanese Urological Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- 5-Aminolevulinic Acid-Based Fluorescence Guidance in Urologic Oncology: Current Status, Pitfalls, and Future Directions.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAlthough photodynamic diagnosis (PDD) using 5-aminolevulinic acid (ALA) is a highly a sensitive and excellent method for detecting nonmuscle-invasive bladder cancer, false-positive rates should not be overlooked. One of the factors causing false-positive results is inflammation. Currently, the relationship between pyuria and PDD accuracy remains unclear. Therefore, this study aimed to clarify the influence of preoperative pyuria on the diagnostic accuracy of PDD.
methodsThis study retrospectively analyzed 101 patients who underwent PDD-assisted transurethral resection of bladder tumors at Kochi Medical School Hospital between January 2018 and December 2020. After dividing the patients into two groups according to the presence or absence of preoperative pyuria, the diagnostic accuracy of each group was analyzed.
resultsA total of 616 specimens from 101 patients were analyzed, among which 460 specimens from 75 patients belonged to the no pyuria group and 156 specimens from 26 patients belonged to the pyuria group. The sensitivity, specificity, positive predictive value, and negative predictive value of PDD were 90.2%, 64.1%, 38.6%, and 96.3% for the no pyuria group and 92.9%, 45.6%, 38.6%, and 94.5% for the pyuria group, respectively. The pyuria group had a lower specificity than did the no pyuria group, indicating a significantly higher false positive rate in the former.
conclusionsOur findings suggest that the presence of preoperative pyuria did not affect the ability of PDD to detect cancer but may increase its false-positive rate and that preoperative pyuria is a useful predictor of false-positive PDD rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.